Kabir Olaniran: Sickle Cell Trait and Chronic Kidney Disease Risk
Kabir Olaniran, Principal Investigator, Sickle Cell Kidney Biorepository of UT Southwestern Medical Center, shared a post on LinkedIn about his recent article, published in CJASN, adding:
“Sickle cell trait has long been designated ‘a benign carrier state’. For the kidney, that label no longer holds.
CJASN invited me to write the editorial on a study by Cai et al (PMID: 41758580) which used metabolomics to provide insights into sickle cell trait kidney injury. In this editorial, I take stock of where the field now stands.
The epidemiology is consistent: a 1.5 to 2 fold independent risk of chronic kidney disease and kidney failure across diverse cohorts. The mechanisms of kidney injury are starting to come into focus from four independent directions: proteomic, microRNA, epigenetic, and metabolomic.
These platforms converge on the same pathways of oxidative stress and nitric oxide dysregulation. This is coherent with the localized renal medullary injury described in sickle cell trait, a condition biologically distinct from sickle cell anemia, and is now supported by a validated murine model.
That convergence has brought the field to a threshold. A carrier population of 300 million worldwide and approximately 3 million in the United States, a plausible organ-specific pathophysiology, and converging multiomic and preclinical evidence justify dedicated, prospective studies spanning childhood through adulthood.
The molecular picture is maturing. The infrastructure to act on it is what we must build next.”
Title: The Metabolomic Landscape of Sickle Cell Trait Nephropathy
Author: Kabir Olaniran
Stay updated with Hemostasis Today.
-
Aug 4, 2026, 20:48New Real-World Data on Efanesoctocog Alfa From France – CRH French Reference Center for Hemophilia Lyon
-
Aug 4, 2026, 20:37Hisam Siddiqi: Haemoglobinopathy Basics – A Quick Guide to Thalassaemia
-
Aug 4, 2026, 20:36Ifeanyichukwu Ifechidere: AI May Soon Interpret Coagulation Results Better Than Some Healthcare Professionals
-
Aug 4, 2026, 20:35Ediga Naga Pradeep Kumar: Excited to Share My Latest Data Analytics Project – Stroke Risk Analysis Dashboard
-
Aug 4, 2026, 20:34Amar Shah: Improving Thrombolysis for Acute Stroke Through Quality Improvement
-
Aug 4, 2026, 20:33Federica Sepe: Are Biomarkers Finally Ready for Precision Stroke Medicine?
-
Aug 4, 2026, 19:57Toby Richards: Iron Deficiency Beyond Anaemia in Female Triathletes
-
Aug 4, 2026, 17:14Edward Lee Carter: Not Every Stroke on a DOAC Is a DOAC Failure
-
Aug 4, 2026, 17:03Meghanath Yenni: Anticoagulant Reversal in Clinical Practice